Daily news email for April 24, 2012 | Click here for updated news

SourceSolution News
We want to hear from you! Click here let us know how we can make this news email better.

Manage projects more efficiently. Try PlanIt free for 15 days.

Create quality questionnaires and RFPs more quickly, weight responses and manage suppliers.

Discounted advertising rates on www.sourcesolution.com for all BIOCOM members starting at $100/month

Use PlanIt as your next deal room! Click here to learn more.

b3c newswire
ARTES Announces a Strategic Collaboration Deal for Vaccine Development

3rd International Definiens Symposium to be Held in Munich from June 14-16, 2012

Labor L+S AG and SYMBIOSIS Form Exclusive Business Alliance

Better Prevention of Transmission and Lesion Development of Genital Herpes Predicted for ...

ElexoPharm Appoints Dr. Chris J. van Koppen as Head of Research

BioSpace
China Cord Blood Corporation Announces $65 Million Investment from Kohlberg Kravis Roberts & Co. L.P.

Pharmaceutical Education and Research Institute (PERI): Biopharma Injected $49.5 Billion in R&D Last Year

Hyperion Therapeutics Files for $58 Million US IPO

Sanofi (France) CEO: Hub's Life Sciences Lead at Risk, Calls for Alliances to Solve Scientic Problems

Left Hand Right Hand, Premature Babies Make the Link, Centre National de la Recherche Scientifique Study

BioSpace - Breaking News
Biogen Idec, Inc. (Massachusetts) Says Phase III Data Highlight Safety Profile For BG-12 MS Drug; Stock Rises +Up 2.14(1.70%) @ 1:22PM EDT

Nordion International Announces Europe-Focused Phase III Clinical Trial for TheraSphere(R) Liver Cancer Treatment

RedHill Biopharma Ltd. Commences a Pivotal Bioequivalence Trial with RHB-103 (An Oral Thin Film for the Treatment of Migraine); Subjects' Recruitment Completed; First Dose Administered; Results Expected within Months

FDA Sent 40 Percent More GMP Letters to Overseas Sites in 2011

Alimera Sciences Release: ILUVIEN(R) Receives Marketing Authorization in Austria for the Treatment of Chronic Diabetic Macular Edema

Biotech News - Business Wire
Precise Biometrics: Resolutions at the Precise Biometrics Annual General Meeting 2012

Medtronic Named One of America's Best Corporate Citizens

Pathway Genomics Adds Prominent Bioinformatics Experts to Scientific Advisory Board

Carolina Liquid Chemistries Brings CLC 720 Chemistry Analyzer to Market

Silicon Biosystems to Present Single-Circulating Tumor Cell Molecular Characterization at the Fourth World CTC Summit

Biotech News - PR Newswire
American Regent Initiates Nationwide Voluntary Recall of Epinephrine Injection, USP, 1:1000, 1 mL Ampules Lot #1395 Due to Discoloration and Small Visible Particles

Kensey Nash Introduces A Novel Biomaterial, Meso BioMatrix Acellular Porcine Peritoneum, For Plastic And Reconstructive Surgery

LABS, Inc. Names Aaron Schieving Business Development Manager

Law Office of Brodsky & Smith, LLC Announces Investigation of Ardea Biosciences, Inc.

RIFM Board Names New President

Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)

Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)

NIH Translational Center Should Raise All Boats, BIO Says

Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update

Biotechnology to be 21st-century industry: Life Tech CEO

Burrill Report
FDA Stretches to Go Global

NICE Rejects Avastin for Breast Cancer

Health IT Deals Hot in Q1

GlaxoSmithKline Steers toward Innovation

Survey: One in Four Americans Had a Gap in Healthcare Coverage in 2011

CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend

New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising

Technology companies adapt interactive video concepts for clinical trial informed consent

CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases

New $1b NIH center will tackle early-stage drug development to ease industry risk of failure

Clinical Trials - Business Wire
The Gateway For Cancer Research Helping Revive Cancer Survivors Garden

eClinicalWorks Opens Chicago Office and Holds 2012 Users Group Meeting

Research and Markets: A Practical Guide to Cluster Randomised Trials in Health Services Research Guides Readers through the Stages of Conducting a Trial, From Recruitment to Reporting

Healthline's Semantic Search Platform Powers Elsevier's ClinicalKey, a Next-Generation Reference Tool for Physicians

ACM Global Central Laboratory Establishes Mumbai-based Subsidiary to Strengthen Lab Services in India

Clinical Trials - PR Newswire
Less Invasive Liver Surgery Technique Easier on Patient, Equally as Safe as Traditional Surgery Method, Study Says

PacificGMP Announces Manufacture of Recombinant Protease Used in Client's Successful Phase 1 Clinical Trial

Eisai Announces Canadian Launch of Halaven (eribulin mesylate) Injection For The Treatment of Metastatic Breast Cancer

Nordion Announces Europe-Focused Phase III Clinical Trial for TheraSphere® Liver Cancer Treatment

LUCASSIN® Approved in Australia

CNN Top Stories
1 dead, 23 hurt in Canadian sawmill blast

Alleged armored truck shooter caught

Manning wants Wikileaks case dropped

1st criminal charges filed in BP oil spill

Murdoch blames employees for hacking

Contract Pharma
3M Drug Delivery Expands Manufacturing Capabilities

AMRI Appoints North American BD Leader

Therapure Opens New Custom Biologics Facility

Merck Serono To Close Geneva HQ

New CEO for Quintiles

FDA Drugs- What's New
FDA Drug Safety Communication: New Warning and Contraindication for blood pressure medicines containing aliskiren (Tekturna)

FDA Drug Safety Communication: Updated information about the risk of blood clots in women taking birth control pills containing drospirenone

Comunicado de la FDA sobre la seguridad de los medicamentos: Recomendaciones modificadas para Celexa (citalopram bromhidrato) relacionadas con el riesgo potencial de ritmo cardiaco anormal con dosis altas

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

Comunicado de la FDA sobre la seguridad de los medicamentos: La interacción entre ciertos medicamentos para el VIH o hepatitis C y los medicamentos con estatinas para reducir el colesterol, puede aumentar el riesgo de lesiones musculares

FDA News - Business Wire
Los resultados positivos del ensayo clínico CONFIRM de Fase 3 demuestran la seguridad y eficacia de BG-12 oral para la esclerosis múltiple

Positive Ergebnisse aus der klinischen Phase-3-Studie CONFIRM zeigen Wirksamkeit und Sicherheit von oral verabreichtem BG-12 bei multipler Sklerose

Becker Consulting Welcomes Six Leading FDA Experts to its Team

Dr. Reddy's Announces the Launch of Olanzapine Tablets

Avvo Releases Avvo Health Advisory (AHA) Providing Insights into Online Consumer Reviews of Medical and Dental Professionals

FDA Press Releases
FDA strengthens international collaboration to ensure quality, safety of imported products

Report: FDA strengthens monitoring of post-approval drug safety

U.S. Marshals seize ultrasound gel product at a New Jersey company

Application

CFP Online Application

FDA Vaccines, Blood and Biologics - What's New
Moon Marine USA Corporation voluntarily recalls frozen raw yellowfin tuna product Nakaochi Scrape associated with a multistate outbreak of Salmonella Bareilly infections

Multi-Center Fellowship in Regenerative Medicine

FDA Webinar on Safety of the Blood Supply

WinRho SDF Liquid

Flebogamma DIF 5%

FierceBiotech
Merck KGaA shuttering Swiss complex, dispatching R&D to Boston

Amgen founding CEO George Rathmann dies at 84

Biogen Idec builds blockbuster case for new MS drug BG-12

Argos and miRagen add new venture rounds to back R&D efforts

AstraZeneca plots more pipeline deals

FierceBiotech IT
Open source sizzles in biotech sphere

FierceBiotech IT in Boston this week

NextBio moves genetic analysis software into clinical R&D territory

Survey: Pharma lags peers in gaining trust via social media

GAO report: FDA's IT modernization 'in jeopardy'

FierceBiotech Research
Johns Hopkins researchers find gene tied to CF secondary complication

Powerful protein halts DNA damage and may block tumors

Swedish scientists identify stem cells that form new brain material

Beyond stem cells: Scientists explore three new paths

Nanotech-boosted drug lessens cerebral palsy symptoms in rabbits

FiercePharma
Merck Serono to cut 580 Swiss jobs, close Geneva HQ

Pradaxa hits blockbuster mark, swelling Boehringer sales

Diovan rivals, plant woes pinch Novartis profits

Novartis wants U.K. to quash off-label Avastin use

What will Amgen's new chief do with $20B cache

FiercePharma Manufacturing
Novartis invests $550 million in flexible, modular processes at new plant

UPDATED: Alli sale still held hostage by Roche GMP issues

Life Technologies expands manufacturing in Scotland

Alli sale still held hostage by Roche GMP issues

China seizes 77 million tainted drug capsules in crackdown

FierceVaccines
Passive vaccine could treat cocaine overdose

Scancell's DNA melanoma vaccine poised for Phase II

Taiwan's RSV vaccine heads toward the clinic

Personalized brain cancer vaccine improves survival

Roche collaborating over AIDS vaccine; TapImmune has licensed cancer antigen;

Health News - BizJournals.com
Sigma-Aldrich's profit falls 1.7 percent in Q1

Talecris acquisition boosts Grifols profit

Health care apps soar in popularity

Carolina Liquid Chemistries launching new blood analyzer

LCA-Vision profit jumps up in 1Q

Health News - CNBC
Movers roundup: Netflix, Sequenom

Montana's Gov. on Getting America Back to Work

When Downsizing Makes Dollars and Sense

CNBC Poll: Do You Plan to Sell Your House to Finance Retirement

Waters slides as 1st-qtr profit falls 6 percent

Health News - Fox Business
Employers Grateful for Proposed Tax Breaks, But Still Scared

Employers Grateful for Proposed Tax Breaks, Still Scared

Insmed Shares Drop as FDA Halts Study After Rat Test Results

Week Ahead: A Flood Of 2Q Earnings

Pfizer Drug Raises Heart Attack Risk: Study

Inside Industry - Gen
Vectura, Novartis' COPD Therapy Succeeds in Fourth Phase III Study

Merck Serono to Close Geneva Headquarters, Relocate Functions to Darmstadt

MiRagen Pockets $20M to Further miRNA-Based Drugs

Poll Majority Confident that Massachusetts Can Maintain Biopharma Construction Boom

BTG Reports Positive Results from Second Phase III Varicose Veins Study

Marketwire - Pharma and Biotech
Development of Cenote Falls Shopping Center Begins in Belize

RECORDATI Acquires Six OTC Products in Germany

GCMI Opens Medical Device Prototyping and Development Facility

Somnia Anesthesia Introduces First Web-Based App for Anesthesia Services

European Life Sciences Executive Search Firm Opens First U.S. Office in Boston

MassBio News
10 reasons to attend the BIO International Convention

New Therapy Helps Patients Soar to New Heights

BIO 2012 Massachusetts Pavillion Patient Profiles

By Popular Demand: New Professional Development Courses Aim to Meet Industry Needs

10 reasons to attend bio international convention

Medical Pharma - PR Newswire
Kensey Nash Corporation Announces Its Third Quarter Fiscal Year 2012 Earnings Release Date and Teleconference

Kaiser Permanente's Benjamin K. Chu, MD Listed Among Modern Healthcare's Top 25 Minority Executives

Billian Adds Home Health & Nursing Home Financials to Healthcare Market Research Line-Up

Calling All ProstRcison Alumni

MEI Healthcare Inc. Partners with Caribbean Countries To Build Multi-million-dollar Regional Oncology Facility

National Center for Biotechnology Information
GTR News

GEO Series Releases

ClinVar News and Announcements

Behind The Headlines - Health News from NHS Choices

PubMed Health Featured Reviews

Nature Biotechnology
Use of genome-wide association studies for drug repositioning

The art of the alliance

Addgene provides an open forum for plasmid sharing

Tensha Therapeutics

Positive signals from Washington

New York Times- Biotechnology
George Rathmann, Chief of Amgen, Dies at 84

Cost of Gene Sequencing Falls, Raising Hopes for Medical Advances

Cancer Center, in Suit, Claims Ex-Official Took Research

Life Sciences Development Rebounds in Central New Jersey

Amgen and Watson to Work Together on Generic Drugs

New York Times- Pharmaceuticals
WELL; Personal Health: Too Much Medicine, and Too Few Checks

The Wrong Way to Stop Fake Drugs

Nebraska: State Will Not Surrender Execution Drug

How Psychedelic Drugs Can Help Patients Face Death

Punjab in the Tight Grip of Addiction

OnBioVC
ImmuneXcite, Inc.: Series A $2.4M

AirXpanders, Inc.: Series D $10.3M

MC10, Inc.: Series B $2M

CN Creative, Ltd.: Series A $3.1M

SEA Medical Systems, Inc.: Series B $3M

Outsourcing-Pharma
Pharmas must give patients voice says DIA Europe director

Improve patient compliance by designing trials around real life, says expert

People special: social media gets job hunters noticed

Regulatory changes: the experts give us their thoughts at DIA Euromeeting

Catalent eyes emerging market expansion of end-to-end development service model

Pharma News - Business Wire
Asteres Awarded Premier Purchasing Contract to Offer PBM Savings to Healthcare Systems

CORRECTING and REPLACING Clinical Data and Interviewed Thought Leaders Indicate Benlysta Has Advantages Over Sales-Leading CellCept for the Treatment of Systemic Lupus Erythematosus

IMS Health Expands Services in Pharma R&D With Acquisition of DecisionView

BioNJ to Host First-Ever Life Sciences Industry HR Conference on May 14

HCCMIS Unveils Interactive Infographic on Immunizations for Travel across the Globe

Pharma News - PharmiWeb
NABP Alerts the Public About Online Drug Sellers Taking Advantage of Drug Shortage Fears

Capital BlueCross Hosts Community Health Care Forums Focused on Managing Costs While Maintaining Quality

Rotary honors U.S. lawmakers for leadership in polio eradication

New Research Reveals One Third of Young Athletes Sidelined Due to Preventable Injuries

BeBevCo Announces KOMA UNWIND Zero Available in the USA

Pharma News - PR Newswire
Soy-Based S-equol Supplement Reduces Hot Flash Frequency, Muscle And Joint Pain In U.S. Postmenopausal Women

Perrigo Company Will Release Third Quarter Fiscal 2012 Results On May 8, 2012

MediPendant to Return to Television on May 20th New Television Campaign - Company Provides MediPendant Update

Fuse Science Partners With GNC To Open National Distribution Of EnerJel

American Academy of Family Physicians Foundation Launches Cities for Life

Pharmaceutical - Moreover
: Pharmaceuticals look to cure pipeline concerns

Drug firms sign up to new tropical disease fight

Cannabis Science Presents Newest Photographs From 3rd Cancer Patient That Show Cancer Tumors Dying and Areas That Are No

Micro Labs attracts private equity and pharma interest: VCCircle

Novartis net dips by 5.3% to Rs.38 crore in Q3

PR Leap - Biotech
Abcam Launches Potent, Novel Dynamin Inhibitor Licensed from the University of Newcastle and Children's Medical Research Institute

Abcam Biochemicals is launched; the new name for Ascent Scientific products

AL-TAR Services, Inc. Adds Thermo-Scientific Product Line to its Online Lab Equipment Store

Ascent Scientific Launch Novel Dynamin Inhibitor Dyngo-4a™ with Children's Medical Research Institute and University of Newcastle

AL-TAR Services, Inc. Names Robert Nugent Director of Business Development

PRWeb - Biotechnology
New HPV Qualification Panel from SeraCare Streamlines Assay...

Dalton Announces Collaboration Developing a Promising Broad Spectrum...

Photonics Sensor R&D will Drive Future Job Creation, SPIE Panel...

Seventh Annual Program in Innovative Remote Sensing Academic Research...

Benchmark Research Recognized as Best Clinical Trial Site at The 2012...

PRWeb - Pharmaceuticals
Genedata Biologics on the Rise at Pharmas and Biotechs

eBottles Adds New Plastic & Glass Bottles to Its Online Inventory

Yaz and Yasmin Litigation Update: Bayer to Pay Minimum of $110 Million...

Vetericyn Reports 50% Distribution Growth in the Past Year; Tops...

PortaFab Introduces New Modular Cleanroom Wall System

Scientific American
Genome Run: Andean Shrub Is First New Plant Species Described by Its DNA

Cheap Fracked Gas Could Help Americans Keep on Truckin'

Second Wind: Air-Breathing Lithium Batteries Promise Recharge-Free Long-Range Driving--If the Bugs Can Be Worked Out

Hot Spring Yields New Hybrid Viral Genome

BFF: Cell Phone Study Shows Evolving Lifetime Relationships in Men and Women

Sports - ESPN Basketball
Sources: Benford new North Texas head coach

Cassell Jr. signs letter of intent with Maryland

O'Neil: Virginia Tech parts ways with Greenberg after nine seasons

Parker commit moves UCLA to head of class

Xavier announces Lyons won't return to school

Sports News - ESPN
Marshall kicks Warren off team; trio disciplined

Witnesses say they weren't afraid of UM player

Liberty Bowl set for New Year's Eve afternoon

South Florida adding ex-Notre Dame DE Lynch

Kansas dismisses 2 for team rules violations

Xconomy Life Sciences
The JOBS ActThe IPO On-Ramp Makes IPOs Easier

George Rathmann, Founding CEO of Amgen and Icos, Dies at 84

AstraZeneca Reloads its Pipeline with Ardea Deal, Could be Still Hunting

Sapphire Energy CEO Jason Pyle's Parting Thoughts on Big Biofuel

Amazon's Fight Against Content Middlemen: Books, TV, Movies, Games

Yahoo Biotech News
Slow, costly process stymies generic biotech drugs (Reuters)

Analysis: Slow, costly process stymies generic biotech drugs (Reuters)

Waves Break Coral Embryo into Identical Twins (LiveScience.com)

Autoinjector Version of MS Drug Approved (HealthDay)

Fake Avastin had salt, starch, chemicals: Roche (Reuters)